Power &
potential

We are advancing a diversified pipeline of potential first-in-class therapeutics for disease targets that have previously evaded drug development. We believe in the power and potential of small molecule drugs to transform how diseases are treated and bring hope to patients around the globe.

PIPELINE

Program
Indication
Research
IND Enabling
Early Clinical
(Phase 1)
Early Clinical
(Phase 2)
Late Clinical
(Phase 3)

ONCOLOGY

Program/Indication
Stage

VVD-037

KEAP1 Activator

Solid tumors

VVD-850

STAT3 Inhibitor

Solid & hematologic tumors

VVD-214

WRN Inhibitor

Solid tumors with microsatellite instability

RAS-PIK3CA Inhibitor

Solid tumors

Undisclosed Targets

Solid tumors

IMMUNOLOGY

Program/Indication
Stage

KEAP1 Inhibitor

Immunology

STAT3 Inhibitor

Immunology

Undisclosed Targets

Immunology

NEUROLOGY

Program/Indication
Stage

Undisclosed Targets

Neurology

PROGRAMS / ONCOLOGY

PROGRAMS / IMMUNOLOGY